Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
Department of Health and Human Services ▸ National Institutes of Health
Description
- What’s being funded: Participation in a collaborative consortium of research centers focused on hepatitis C virus (HCV) vaccine research.
- Main goal: Design, optimize, evaluate, and develop broadly protective HCV vaccine candidates and move the most promising ones into clinical evaluation.
- What participants will do: Conduct coordinated research to improve vaccine concepts, test their effectiveness, and advance candidates toward clinical trials.
- Who should cons…
The purpose of this notice of funding opportunity (NOFO) is to solicit applications to participate in a consortium of Research Centers focused on designing, optimizing, evaluating, and developing broadly protective vaccines for hepatitis C virus to enable the advancement of vaccine candidates in…
Source
Grant ID
RFA-AI-25-012
Funding Source
Department of Health and Human Services ▸ National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- City or township governments
- County governments
- For profit organizations other than small businesses
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Private institutions of higher education
- Public and State controlled institutions of higher education
- Public housing authorities/Indian housing authorities
- Small businesses
- Special district governments
- State governments
Additional Eligibility Information
Other Eligible Applicants include the following:
Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; U.S. Territory or Possession.
Awards & Funding
Total Funding
$8.3M
Award Ceiling
$2M
Funding Amount
Discretionary
Links
Documents
Similar opportunities
- Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
- Notice of Special Interest (NOSI): Epigenetic Modulation of HBV cccDNA and integrated HBV DNA (iDNA): Implications for Epigenetic Treatment Strategies Against HBV in HIV/HBV Co-Infection
- Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine
- Notice of Special Interest (NOSI): Promoting Research and Development of Vaccines Against Enteric Viruses
- Notice of Funding Opportunity for AIDS Prophylactic Vaccine Discovery Research